QOP
MBIO icon

Quinn Opportunity Partners’s Mustang Bio MBIO Stock Holding History

Quinn Opportunity Partners’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45
Closed -$91K – 239
2021
Q3 		$91K Hold
45
– – 0.01% 244
2021
Q2 		$113K Hold
45
– – 0.01% 228
2021
Q1 		$113K Hold
45
– – 0.01% 240
2020
Q4 		$129K Hold
45
– – 0.01% 217
2020
Q3 		$107K Hold
45
– – 0.01% 186
2020
Q2 		$108K Hold
45
– – 0.01% 171
2020
Q1 		$91K Hold
45
– – 0.01% 161
2019
Q4 		$139K Sell
45
-2
-4% -$4.58K 0.02% 153
2019
Q3 		$116K Hold
47
– – 0.01% 168
2019
Q2 		$131K Buy
+47
New +$134K 0.02% 170

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Quinn Opportunity Partners's MBIO Position: Q4 2021 in Review

Quinn Opportunity Partners sold out of Mustang Bio (MBIO) in Q4 2021, closing a stake of 45 shares — an estimated $91K sold.

Quinn Opportunity Partners first reported a position in MBIO in Q2 2019 and held it in 10 quarters. The position peaked at $139K in Q4 2019. 83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

  • Quinn Opportunity Partners reported no remaining Mustang Bio position as of Q4 2021 after selling out during the quarter.
  • Quinn Opportunity Partners sold 45 Mustang Bio shares in Q4 2021, an estimated $91K.
  • Quinn Opportunity Partners first reported a position in Mustang Bio in Q2 2019 and held it in 10 quarters.
  • Quinn Opportunity Partners's Mustang Bio position peaked at $139K in Q4 2019.
  • 83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on Quinn Opportunity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.